疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

% D3 G: r6 B; t9 UApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

3 W2 g) V* C. }! zhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
3 S9 H# X% g7 U# O: J) p
SECTION 1: General aspects of vaccination
& S: r- ^/ z( V2 H) f1 A short history of vaccination 1
; C, T$ ?, Y, \2 Vaccine immunology 14
3 The vaccine industry 33
* O/ _# [7 e* y2 K' T; Y4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
  s4 v6 v4 Y/ c6 Vaccine additives and manufacturing residuals in the United States:
. ~" i1 ?& D& f6 u/ X  h6 m( |licensed vaccines 71
$ \4 y5 F5 k- D, `# X7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
) p% r0 ^- {2 u! D# D9 Adenovirus vaccines 113
4 b8 o2 |5 O8 x2 j1 v10 Anthrax vaccines 127
3 ^6 R# I" K  e6 p5 l( p- w11 Cholera vaccines 141
12 Diphtheria toxoid 153
: O7 a( N; `0 [5 X# Q9 d" h: }13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
. q6 W. m9 [0 p5 K; H16 Human papillomavirus vaccines 235
6 F8 Q! H" c3 L2 W6 z9 f9 |* [/ e8 G17 Inactivated influenza vaccines 257
) `" a1 b* x" d1 l. [# {. y18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
+ b1 M' Z; z% [; l! V20 Measles vaccines 352
' l: o# g- q8 B  f21 Meningococcal vaccines 388
+ e. O$ N8 c4 q% o3 t$ H22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
, z% p) z( H& v+ `26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
# p: g; b* k; g7 L/ w2 Q/ f& l4 Y30 Rotavirus vaccines . 669
$ t% z) e/ d; k! e5 f4 l31 Rubella vaccine 688
32 Smallpox and vaccinia 718
0 C$ Y- E9 S) m( V* e' K33 Tetanus toxoid 746
2 p4 h7 G* I9 B2 T- Q34 Tick-borne encephalitis virus vaccines 773
% ]$ `, c: K" j. v5 V) u35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
) V2 J* g: i' H6 x! H38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
5 x* r* g* c3 @+ n& w/ ?SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
- Q# X1 O0 [, r1 h0 K; l" C42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
7 k; D& N' z  I8 @: s8 {45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
; c; o1 d1 z% X0 K1 W' [3 j# z47 Epstein-Barr virus vaccines 1068
; o! q0 P; `# u2 _- r48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
9 k; z5 p5 |7 `4 M9 C1 j53 Malaria vaccines 1133
: [1 D8 D6 b' s54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
4 `8 q* }& i) N0 G0 o" _0 T56 Parasitic disease vaccines 1154
6 N9 n' X0 Q7 y( y1 J; ^. b57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
* ^# u! D. [3 R: g3 y' U1 n* x9 b59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
* [" p( E; y4 p" O; m61 Alternative vaccine delivery methods 1200
! v2 s6 ~6 c. ^( |62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
4 R4 e# L6 ^0 U1 W! i' F% J) A63 Vaccination of immunocompromised hosts 1243
1 r, U# ~$ G2 K. T; Y- q' R8 @64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
, [# ~7 M7 D8 P" [) V; X66 Vaccines for health care personnel 1290
8 U/ `, G7 a2 |# L6 l1 ISECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
" _/ U( n. {2 G; u, B69 Immunization in the Asia-Pacific region 1353
/ E" }6 J8 {) ?! D: @70 Immunization in developing countries 1369
71 Community immunity 1395
* T9 [5 W5 t. ?. ~/ c72 Economic analyses of vaccine policies 1413
$ K% ]! E% ?$ q1 G* ?73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

3 N# ]' Q) Q/ `$ a/ F8 j


) @- U% ~4 c: [7 v5 Y  V

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

' c- ?* y+ x$ @# u. IVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

0 {$ e1 ^0 Z, E6 P& B# z8 hhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
2 u: l! H8 c0 G3 P5 M7 V
SECTION 1: General aspects of vaccination
+ H1 x( B) J+ n1 A short history of vaccination 1
( R! n8 r' O6 a+ r% |, E, F% m; G2 Vaccine immunology 14
9 H! d- ?% X! x* W" v3 The vaccine industry 33
4 Vaccine manufacturing 44
9 Z. I9 }- {  f8 R9 {5 Evolution of adjuvants across the centuries 58
5 ^2 _" v5 j: n" y; N' L6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
# B& N1 {, P/ d( m- L& s: i0 s7 Passive immunization 80
8 General immunization practices 88
$ P8 v$ _' X  C; ESECTION 2: Licensed vaccines
  T, D) Y/ H9 X% Z, h+ i9 Adenovirus vaccines 113
+ O0 I. i. B0 G5 f) k& c10 Anthrax vaccines 127
  ^+ ]' R) ^2 u* h9 E4 Z11 Cholera vaccines 141
12 Diphtheria toxoid 153
% E3 C) y. {/ E' m5 U& m13 Haemophilus influenzae vaccines 167
$ o3 u9 Z3 a  Y* E2 G+ O$ Q14 Hepatitis A vaccines 183
4 }1 Z. h7 y% ]- ^. c6 z; y15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
' D( u; i' z0 h0 p  b  h+ }( a2 Q19 Japanese encephalitis vaccines 312
0 z8 T! {7 _/ F- Z  o20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
  @' h$ Q7 d8 D& E% j4 `& D1 s( ~24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
( j  J' M8 y0 J1 A29 Rabies vaccines .646
( s) \/ x: r) L7 {. k& X, X30 Rotavirus vaccines . 669
- J- K9 C% Q/ ?31 Rubella vaccine 688
! B* `1 ]1 C; B* n# v4 e  E/ K32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
, x8 E+ h. J$ Y1 }; L5 T( `34 Tick-borne encephalitis virus vaccines 773
% Q/ d! B9 T" \* O6 f7 {( _35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
: k" e$ B$ w5 L9 ^, E, F39 Zoster vaccine 969
40 Combination vaccines 981
% M( k3 L/ \# W0 k5 L6 |3 OSECTION 3: Vaccines in development and new vaccine strategies
" q% p; ~' w' K41 Biodefense and special pathogen vaccines 1008
$ V  i' s$ j. i2 g* Y( U4 u42 Therapeutic cancer vaccines 1018
6 ^" @6 Z% X  G' t, {43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
8 N, r0 a7 @5 ]! T& U' y48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
) N8 r/ m7 T# L51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
+ k9 U0 j! Y2 C54 Noninfectious disease vaccines 1138
2 M- S, c, k1 w. q2 \* ^55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
  I) a7 L4 N; W7 Q, m57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
0 ?; q/ I. k5 @3 K4 Z59 Streptococcus group B vaccines 1176
+ o/ ^! j" k7 J1 E, w) [4 R: b60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
; K7 y" O3 L4 w6 `62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
0 d' k6 m6 W1 m, y5 _0 s63 Vaccination of immunocompromised hosts 1243
/ E0 n4 G9 v+ x$ s& L: b3 l. y+ w64 Vaccination of human immunodeficiency virus-infected persons 1257
) E% a+ I! c8 i2 S* k# Y5 W" R& m65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
5 r1 B, @7 }. d3 F68 Immunization in Europe . 1334
" f2 G6 J) [. b$ o69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
( M$ Q- @1 F, I- L! ], Y# E74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508


0 `" Z( y7 J5 G$ P3 t

casarett

Vaccines, 6e, 2012

- G0 }1 R- r1 A( x' f: GHardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
Language: English
" A0 R5 \/ a$ z) m+ _7 AISBN-10: 1455700908
$ q2 V; x) o' O+ J/ _) r% h/ M* _Size: 52.3mb (original pdf)

2013 BMA Medical Book Awards Highly Commended in Public Health!
2 g; i. c% O3 Y* _% MApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
$ g8 V( z! h& i5 ]# V0 `; T4 AAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
# W/ d/ J0 k' G/ BClearly visualize concepts and objective data through an abundance of tables and figures.
  J* ]1 Q6 L" G" y. I) ]- }" rPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
; ~( G% p, R" ]( f6 mCode for downloading: dv96